Close this search box.

Table of Contents

New Indications


New Indications, in financial terms, refers to updated information or signals about the interest level in a new security offering prior to its issuance. It provides potential investors, underwriters, and issuers insights into the possible pricing and demand for a specific security. It is a non-binding yet crucial part of the process for the issuance of new securities.


The phonetic pronunciation of “New Indications” is: nuː ɪn.dɪˈkeɪ.ʃənz

Key Takeaways

New Indications is quite a broad topic, so the takeaways might vary depending on the specific context. However, here’s a general overview.“`html

  1. Definition: New Indications generally refers to additional, approved uses for a drug or medical device that were not part of the original approval by regulatory bodies like the FDA. This usually implies further research and clinical trials demonstrating its safety and effectiveness for these new purposes.
  2. Process: The process for identifying, researching and getting approval for New Indications is rigorous and lengthy, involving pre-clinical and clinical studies, data analysis, and regulatory review. This process ensures that the treatment is safe and effective for the new use.
  3. Impact: When successful, New Indications have the potential to greatly expand patient options for treatment, potentially offering new fixes for unmet needs in healthcare. For pharmaceutical companies, this can also mean expanded markets for their products.



New Indications is a significant term in business and finance because it represents potential market opportunities for a product, especially in the pharmaceutical and medicinal industries. Typically, the term refers to new uses that have been identified for a drug or treatment, beyond its originally approved purpose. These new indications can considerably extend the lifespan and profitability of a product, by expanding its reach to new customer bases and potentially transforming it into a groundbreaking, multi-purpose solution. As such, new indications are often associated with increased revenue streams, contributing to the overall financial growth and resilience of a company. Hence, they are an essential aspect of strategic planning and investment considerations.


New indications are primarily used in the pharmaceutical and healthcare industry, relating to the discovery or development of new uses for an existing drug. This term refers to instances where pharmaceutical companies seek to expand the use of a specific drug by identifying new diseases or conditions that the drug can effectively treat. After the initial approval by the food and drug administration (FDA) or a similar regulatory body, subsequent exploration by the pharmaceutical company can unveil different or expanded therapeutic uses for the drug, which are referred to as ‘new indications.’New indications are significant for pharmaceutical companies as they can extend the life and profitability of a drug. The identification of a new indication can mean potentially prolonging a drug’s patent life, thereby securing additional revenue streams. Additionally, new indications can help a pharmaceutical company stand out in a competitive marketplace, particularly if the new indication targets a disease or condition with few existing treatment options. The process of identifying and testing new indications can also lead to better patient outcomes, as it may offer a new or improved treatment option for certain medical conditions.


1. Pharmaceutical sector: A common application of the term new indications is in the pharmaceutical industry. For instance, the company Pfizer’s drug, Viagra, originally intended for the treatment of angina (a heart condition), showed a new indication as a treatment for erectile dysfunction during its phase of clinical testing. This new indication significantly expanded its potential market and revenue.2. Technology sector: Apple Inc.’s iPhone is another example of a product with new indications. Initially launched as a simple communication device, new indications (or uses) were later introduced in updates and newer models such as camera functions, internet surfing capabilities, gaming platform, and even a mobile payment system. These added functions provided new growth opportunities for Apple.3. Energy sector: A third example can be found in the use of solar panels for energy production. Originally, solar panels were only used in locations without access to traditional power grids or for environmental reasons. However, with increasing technological advancements and cost reductions, new indications emerged such as use in mainstream residential areas as backup power supply or even as primary power source to save utility costs. This significantly expanded the market share for solar energy companies.

Frequently Asked Questions(FAQ)

What are New Indications in finance and business?

New Indications are changes or updates in a company’s financial or operational situation, which may have a potential impact on the company’s value, stock price, or future performance. These can include product launches, management changes, market trends, or any other significant organizational developments.

How do New Indications affect a company’s stock price?

New Indications might affect a company’s stock price depending on the nature of the changes or updates. Positive developments usually increase stock prices, whereas negative ones can cause a fall. However, predictions about the market’s reaction are not always accurate since they can be influenced by other factors as well.

How are New Indications usually communicated?

Companies often communicate New Indications through press releases, announcements to shareholders, reports filed with governmental regulatory bodies like the Securities and Exchange Commission (SEC), or during their quarterly earnings calls.

How should investors track New Indications?

Investors can track New Indications by following a company’s press releases, financial reports, media coverage, or through subscription-based financial news services. Staying informed can help investors make timely and informed decisions.

What happens if a company does not disclose New Indications properly?

If a publicly-traded company fails to disclose New Indications that could materially affect the stock price in a timely manner, they could face penalties from regulatory bodies, legal action, or lose investor trust.

How do New Indications affect business analysis?

New Indications provide vital data for business analysis. They might indicate a company’s growth potential, risk factors, competitive position, and management effectiveness. Hence, they play a significant role in developing business strategies and making investment decisions.

How can I analyze the impact of New Indications on a company’s financial health?

Analyzing the impact of New Indications involves deep scrutiny of financial statements, press releases, market trends, and industry analysis. It may also require professional expertise to interpret the financial impact. This analysis can help forecast potential changes to a company’s financial health and profitability.

Related Finance Terms

  • Phase I Clinical Trials
  • Drug Development
  • FDA Approval Process
  • Intellectual Property Rights in Pharmaceutical Industry
  • Market Exclusivity

Sources for More Information

About Our Editorial Process

At Due, we are dedicated to providing simple money and retirement advice that can make a big impact in your life. Our team closely follows market shifts and deeply understands how to build REAL wealth. All of our articles undergo thorough editing and review by financial experts, ensuring you get reliable and credible money advice.

We partner with leading publications, such as Nasdaq, The Globe and Mail, Entrepreneur, and more, to provide insights on retirement, current markets, and more.

We also host a financial glossary of over 7000 money/investing terms to help you learn more about how to take control of your finances.

View our editorial process

About Our Journalists

Our journalists are not just trusted, certified financial advisers. They are experienced and leading influencers in the financial realm, trusted by millions to provide advice about money. We handpick the best of the best, so you get advice from real experts. Our goal is to educate and inform, NOT to be a ‘stock-picker’ or ‘market-caller.’ 

Why listen to what we have to say?

While Due does not know how to predict the market in the short-term, our team of experts DOES know how you can make smart financial decisions to plan for retirement in the long-term.

View our expert review board

About Due

Due makes it easier to retire on your terms. We give you a realistic view on exactly where you’re at financially so when you retire you know how much money you’ll get each month. Get started today.

Due Fact-Checking Standards and Processes

To ensure we’re putting out the highest content standards, we sought out the help of certified financial experts and accredited individuals to verify our advice. We also rely on them for the most up to date information and data to make sure our in-depth research has the facts right, for today… Not yesterday. Our financial expert review board allows our readers to not only trust the information they are reading but to act on it as well. Most of our authors are CFP (Certified Financial Planners) or CRPC (Chartered Retirement Planning Counselor) certified and all have college degrees. Learn more about annuities, retirement advice and take the correct steps towards financial freedom and knowing exactly where you stand today. Learn everything about our top-notch financial expert reviews below… Learn More